Study populations

Argentina, in 2016, had an estimated population of 46.3m with some 33% under the age of 20 years and 15% over the age of 60 years. By 2040, the age distribution is expected to dramatically change with those over the age of 60 years representing 20% (10.9m) of the population.

Alongside the ageing population, diabetes prevalence is increasing – with the most recent statistics reporting 1.7m people living with the condition and an estimated 592,600 undiagnosed cases.

Report & Infographic

Cover page for Argentina Study Report. For accessible PDF version of full report click the image.
Info-graphic containing overview of findings. For an accessible PDF please click the image.

Time of presentation for screening with an ophthamologist

0% In time for screening, 88.9% When visual problems have already occurred, 11.1% Too late for effective treatment
(Ophthamologists n=48)
In time for screening When visual problems have already occurred Too late for effective treatment

Availability of DR patient education materials in health care providers’ offices

36.8% Sufficient information available, 10.5% Information not sufficient, 47.3% No written information available 5.3% Don’t know
(All providers n=109)
Sufficient information available Information not sufficient No written information available Don’t know

Complications adults with diabetes were most concerned about

43.5% Vision loss, 23.1% Kidney disease, 15.7% Cardiovascular disease/stroke, 7.4% Amputation
(Adults with diabetes n=50)
Vision loss Kidney disease Cardiovascular disease/stroke Amputation

Frequency of discussions about eye complications with health care providers

21.1% Every visit, 22% Multiple times per year, 32.1% Once a year, 13.8% When symptoms arise, 6.4% Never
(Adults with diabetes n=48)
Every visit Multiple times per year Once a year When symptoms arise Never

The DR Barometer Community is a growing multidisciplinary network of thought leaders and organizations who are working together to address gaps in diabetes patient care. Join today to help improve vision health outcomes among people living with diabetes.